ArticleScientific reports2026
Predicting infected pancreatic necrosis in acute pancreatitis using machine learning models and feature selection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Infected pancreatic necrosis (IPN) is a life-threatening complication of acute pancreatitis (AP), and its early prediction remains challenging. This study aimed to develop and externally validate interpretable machine learning models for individualized IPN risk prediction. A total of 728 patients with AP admitted to Xuanwu Hospital, Capital Medical University, between 2017 and 2023 were retrospectively analyzed. Embedded feature selection was incorporated within model training using regularized linear and tree-based algorithms to enhance interpretability and prevent overfitting. Five machine learning algorithms and one neural network model were evaluated through nested cross-validation and an independent temporal external cohort consisting of 166 AP patients admitted to Xuanwu Hospital, Capital Medical University, between 2022 and 2023. Model discrimination, precision-recall, and probability calibration were assessed, and model explainability was analyzed using Shapley Additive Explanations (SHAP). The Random Forest model achieved the best overall performance, achieving an external AUC of 0.764 (95% CI 0.696-0.830, [Formula: see text]), precision of 0.893, recall of 0.604, and the lowest Brier score, indicating reliable probability calibration. SHAP analysis identified Fibrinogen, APACHE II score, D-dimer, IL-6, and C-reactive protein as key predictors associated with increased IPN risk, while higher Lymphocyte count, and Hematocrit were protective. These findings are consistent clinical pathophysiology. The interpretable Random Forest model demonstrated robust discrimination and calibration for IPN prediction, providing a transparent and data-driven framework for early risk stratification in acute pancreatitis. Prospective multicenter validation is warranted before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.